APA (7th ed.) Citation

Fons, P., Gomez-Roca, C., Cassier, P., Delord, J., Rochaix, P., Korakis, I., . . . Friend, J. (2025). 214eP Exploratory biomarkers evaluation to enhance characterization and explore treatment response prediction in metastatic ovarian cancer patients undergoing therapy with EVT801, a highly selective VEGFR-3 inhibitor. Annals of Oncology, 36, S290. https://doi.org/10.1016/j.annonc.2025.08.646

Chicago Style (17th ed.) Citation

Fons, P., et al. "214eP Exploratory Biomarkers Evaluation to Enhance Characterization and Explore Treatment Response Prediction in Metastatic Ovarian Cancer Patients Undergoing Therapy with EVT801, a Highly Selective VEGFR-3 Inhibitor." Annals of Oncology 36 (2025): S290. https://doi.org/10.1016/j.annonc.2025.08.646.

MLA (9th ed.) Citation

Fons, P., et al. "214eP Exploratory Biomarkers Evaluation to Enhance Characterization and Explore Treatment Response Prediction in Metastatic Ovarian Cancer Patients Undergoing Therapy with EVT801, a Highly Selective VEGFR-3 Inhibitor." Annals of Oncology, vol. 36, 2025, p. S290, https://doi.org/10.1016/j.annonc.2025.08.646.